Related references
Note: Only part of the references are listed.Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives
Jingjing Qu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A for Nonrandomized, Open-label, Phase II Trial
Jianming Xu et al.
CLINICAL CANCER RESEARCH (2021)
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Bossi et al.
ANNALS OF ONCOLOGY (2021)
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
Yu-Pei Chen et al.
MOLECULAR CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study
Xiaolan Ruan et al.
CANCER (2021)
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
Liam Masterson et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology
Ya-Qin Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer
Mayumi Sawada et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
Ya-Qin Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Vascular endothelial growth factor signaling in development and disease
Sinem Karaman et al.
DEVELOPMENT (2018)
Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study
Ya-Qin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
NCCN Guidelines® Insights Head and Neck Cancers, Version 1.2018 Featured Updates to the NCCN Guidelines
A. Dimitrios Colevas et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang et al.
LANCET ONCOLOGY (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
Jin-Zhang Cheng et al.
CANCER CELL INTERNATIONAL (2018)
A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis
Feng Wang et al.
FRONTIERS IN ONCOLOGY (2018)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton et al.
JAMA ONCOLOGY (2016)
Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma
Xue Hou et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
Dongxian Jiang et al.
BMC CANCER (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Jiang Li et al.
ONCOIMMUNOLOGY (2015)
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
J. M. Juergensmeier et al.
BRITISH JOURNAL OF CANCER (2013)
HOW DOES INTENSITY-MODULATED RADIOTHERAPY VERSUS CONVENTIONAL TWO-DIMENSIONAL RADIOTHERAPY INFLUENCE THE TREATMENT RESULTS IN NASOPHARYNGEAL CARCINOMA PATIENTS?
Shu-Zhen Lai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
RE-EVALUATION OF 6TH EDITION OF AJCC STAGING SYSTEM FOR NASOPHARYNGEAL CARCINOMA AND PROPOSED IMPROVEMENT BASED ON MAGNETIC RESONANCE IMAGING
Yan-Ping Mao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Synergy between tumor immunotherapy and antiangiogenic therapy
S Nair et al.
BLOOD (2003)
Share Paper
